2002
DOI: 10.1016/s0022-510x(02)00188-0
|View full text |Cite
|
Sign up to set email alerts
|

Successful immune treatment for non-paraneoplastic limbic encephalitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
14
0
2

Year Published

2002
2002
2018
2018

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 37 publications
(16 citation statements)
references
References 8 publications
0
14
0
2
Order By: Relevance
“…In our case, disease progression despite steroid treatment [6,7] required a more aggressive immunotherapy with immunoglobulin [8] and azathioprine, which apparently are good alternative treatment options in NPLE without sufficient response to steroid treatment. Under this medication, there was a partial neuropsychological improvement and a decline of the VGKC-Ab levels.…”
Section: Sirsmentioning
confidence: 78%
“…In our case, disease progression despite steroid treatment [6,7] required a more aggressive immunotherapy with immunoglobulin [8] and azathioprine, which apparently are good alternative treatment options in NPLE without sufficient response to steroid treatment. Under this medication, there was a partial neuropsychological improvement and a decline of the VGKC-Ab levels.…”
Section: Sirsmentioning
confidence: 78%
“…LE can be classified, according to its pathogenesis, into three categories; paraneoplastic, infectious, and autoimmune-related [17][18][19]. Recent studies indicate that some central nervous system antibodies such as VGKC-Abs are related to autoimmune-mediated LE [20].…”
Section: Discussionmentioning
confidence: 99%
“…The 4 antibody-positive patients had no findings of viral infection or cancer. Several reports have been published concerning the immunotherapy response form of nonparaneoplastic limbic encephalitis [21,22,23,24,25,26]. Recently, a VGKC antibody has been detected in patients with reversible autoimmune limbic encephalitis [27,28,29,30,31,32].…”
Section: Discussionmentioning
confidence: 99%